- Sun Pharma to Acquire Checkpoint Therapeutics PR Newswire
- Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million or over Rs 3,000 crore Moneycontrol
- Sun Pharma to buy US-based oncology firm with new skin cancer treatment product for $355 million Hindustan Times
- Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mn The Economic Times
- Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher Mint
Sun Pharma to Acquire Checkpoint Therapeutics PR NewswireSun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million or over Rs 3,000 crore MoneycontrolSun Pharma to buy US-based oncology firm with new skin cancer treatment product for $355 million Hindustan TimesSun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mn The Economic TimesSun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher Mint Top stories – Google News